rs201835155
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_176787.5(PIGN):c.1694G>T(p.Arg565Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 1,607,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_176787.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGN | NM_176787.5 | c.1694G>T | p.Arg565Leu | missense_variant | Exon 19 of 31 | ENST00000640252.2 | NP_789744.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGN | ENST00000640252.2 | c.1694G>T | p.Arg565Leu | missense_variant | Exon 19 of 31 | 1 | NM_176787.5 | ENSP00000492233.1 | ||
PIGN | ENST00000400334.7 | c.1694G>T | p.Arg565Leu | missense_variant | Exon 18 of 30 | 1 | ENSP00000383188.2 | |||
PIGN | ENST00000638424.1 | n.1694G>T | non_coding_transcript_exon_variant | Exon 17 of 29 | 5 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 151966Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 239518Hom.: 0 AF XY: 0.00000772 AC XY: 1AN XY: 129606
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1456016Hom.: 0 Cov.: 31 AF XY: 0.00000553 AC XY: 4AN XY: 723616
GnomAD4 genome AF: 0.0000855 AC: 13AN: 151966Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74198
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Pathogenic:2Uncertain:2
- -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
- -
This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 565 of the PIGN protein (p.Arg565Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of PIGN-related conditions (PMID: 32220244, 35322241; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 391067). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PIGN protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1Uncertain:1
Reported in a patient with features consistent with a PIGN-related disorder who had a second PIGN variant in trans (PMID: 32220244); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35322241, 38256219, Xiuwei_2021, 38456468, 32220244) -
PIGN: PM2, PM3 -
Inborn genetic diseases Pathogenic:1
The p.R565L variant (also known as c.1694G>T), located in coding exon 16 of the PIGN gene, results from a G to T substitution at nucleotide position 1694. The arginine at codon 565 is replaced by leucine, an amino acid with dissimilar properties. This variant has been confirmed in trans with a PIGN likely pathogenic/pathogenic variant in two individuals with clinical features of PIGN-related glycosylphosphatidylinositol deficiency (Ambry internal data; Brea-Fernández AJ et al. Eur J Hum Genet, 2022 Aug;30:938-945). Another alteration at the same codon, c.1694G>A (p.R565H), has been detected in an individual with clinical features consistent with PIGN-related glycosylphosphatidylinositol deficiency (Jiao X et al. Orphanet J Rare Dis, 2020 Mar;15:78). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
not specified Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at